Not surprisingly, finding the magic bullet has become the holy grail for Alzheimer’s researchers. But it’s proving to be an ...

A team of researchers from the Institute for Basic Science (IBS) in South Korea has made an important discovery that could ...

The technology – called Antibody Transport Vehicle (ATV): Amyloid beta – can be used to help amyloid-targeting drugs cross the blood brain barrier (BBB) more effectively, say the partners.

Through that electric field, amyloid beta peptides establish a positive feedback loop that accelerates production and ...

A new way to deliver disease-fighting proteins throughout the brain may improve the treatment of Alzheimer's disease and other neurological disorders, according to University of California, Irvine ...

We examined acetylcholinesterase, plasma neuronal proteins, secreted beta-amyloid precursor protein (APP), and amyloid-beta 40 and amyloid-beta 42 peptides in children with and without autism.

Panelists discuss how hesitancy in prescribing amyloid-targeting therapies stems from multiple factors including concerns ...

Although there are many outstanding questions about Alzheimer’s and a significant lack of effective drugs, scientists believe a protein called amyloid-beta plays an important role in the condition.

In separate experiments with mice, oral infection with the pathogen led to brain colonization by the bacteria, together with ...